Abiopharma

Clinical trial NCT03630640: status: COMPLETED → TERMINATED.

Clinical trial NCT06247995 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 58 → 20 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05395481 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-05-12 3. primary completion date: 2026-05-01 → 2026-05-12 4. enrollment: 176 → 115 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05566665 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2025-12-31 → 2026-03-31

Clinical trial NCT03283917 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-05-18 → 2026-06-17 3. primary completion date: 2027-05-18 → 2026-06-17

Clinical trial NCT07601243 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-06-02

Clinical trial NCT02593994 updates: 1. completion date: 2030-12-31 → 2031-12-31 2. primary completion date: 2026-12-31 → 2027-12-31

Clinical trial NCT07414992: start date: 2026-05-01 → 2026-07-01.

Clinical trial NCT01192425 updates: 1. start date: not set → 2010-09-01 2. completion date: not set → 2010-09-01 3. primary completion date: not set → 2010-09-01

Clinical trial NCT07534592 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-09-18 → 2026-08-28 3. primary completion date: 2026-09-18 → 2026-08-28 4. enrollment: 40 → 48 participants 5. enrollment type: ESTIMATED → ACTUAL